Literature DB >> 17288546

Prions and prion diseases.

Michael Beekes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17288546     DOI： 10.1111/j.1742-4658.2006.05629.x

Source DB:  PubMed          Journal:  FEBS J        ISSN： 1742-464X            Impact factor:   5.542


× No keyword cloud information.
  5 in total

1.  Binding of bovine T194A PrP(C) by PrP(Sc)-specific antibodies: potential implications for immunotherapy of familial prion diseases.

Authors:  Claudia A Madampage; Pekka Määttänen; Kristen Marciniuk; Robert Brownlie; Olga Andrievskaia; Andrew Potter; Neil R Cashman; Jeremy S Lee; Scott Napper
Journal:  Prion       Date:  2013-05-31       Impact factor: 3.931

2.  Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity.

Authors:  Xing Wei; Yvonne Roettger; Bailin Tan; Yongzheng He; Richard Dodel; Harald Hampel; Gang Wei; Jillian Haney; Huiying Gu; Brian H Johnstone; Junyi Liu; Martin R Farlow; Yansheng Du
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

3.  Comparative analysis of heparin affecting the biochemical properties of chicken and murine prion proteins.

Authors:  Li-Juan Wang; Xiao-Dan Gu; Xiao-Xiao Li; Liang Shen; Hong-Fang Ji
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

Review 4.  Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy.

Authors:  Kristen Marciniuk; Ryan Taschuk; Scott Napper
Journal:  Clin Dev Immunol       Date:  2013-10-20

Review 5.  Prion diseases: immunotargets and therapy.

Authors:  Jennifer T Burchell; Peter K Panegyres
Journal:  Immunotargets Ther       Date:  2016-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.